OPNT Opiant Pharmaceuticals Inc.

Opiant Pharmaceuticals Inc is a specialty pharmaceutical company. The Company develops opioid pharmacological treatments for substance use, addictive and eating disorders.

As of 10/15/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  4,399,675
Average volume:  78,836
Market cap:   $109,155,937
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    683750103
ISIN:        US6837501039
Valuation   (See tab for details)
PE ratio:   -54.52
PB ratio:   2.74
PS ratio:   0.00
Return on equity:   -3.08%
Net income %:   -3.06%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy